14-day Premium Trial Subscription Try For FreeTry Free

HBIO Upcoming Earnings (Q4 2023)

Earnings Date: Mar 14, 2024
Consensus EPS: Premium

Current P/E* ratio: -57.30 | Price (Feb 28, 2024, EOD): $4.38

*The P/E ratio (price-to-earnings ratio) is a financial metric used to assess a company's stock valuation. It is calculated by dividing the stock price by its earnings per share. A higher ratio suggests higher investor expectations, while a lower ratio may indicate undervaluation. It helps investors evaluate potential investments, but it's essential to consider other factors too.

Earnings Per Share

Last 3 Quarters for HBIO Premium

Below you can see how HBIO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Earnings Report Demo



When is the earnings report for HBIO?
Harvard Bioscience (HBIO) has scheduled its earnings report for Mar 14, 2024 before the markets open.

What is the HBIO price-to-earnings (P/E) ratio?
HBIO P/E ratio as of Feb 28, 2024 (TTM) is -57.17.

What is the HBIO EPS forecast?
The forecasted EPS (Earnings Per Share) for Harvard Bioscience (HBIO) for the first fiscal quarter 2023 is $0.0500.

What are Harvard Bioscience's retained earnings?
On its balance sheet, Harvard Bioscience reported retained earnings of $25.36 million for the latest quarter ending Sep 30, 2023.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.

Click to get the best stock tips daily for free!

About Harvard Bioscience

Harvard Bioscience Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgic... HBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE